lnc‐ITSN1‐2 expression was positively associated with the levels of CRP (r = 0.398, P < .001), TNF‐α (r = 0.502, P < .001), IL‐1β (r = 0.313, P < .001), IL‐6 (r = 0.207, P < .001), IL‐8 (r = 0.400, P < .001), IL‐17 (r = 0.272, P < .001), and IL‐22 (r = 0.222, P < .001) in AIS patients (Table 3). This evidence concerns the gene CXCL8 and androgen insensitivity syndrome.